[The concept and history of biomarker].

Ryoji Nonaka, Junichi Nishimura, Masaki Mori

Research output: Contribution to journalReview article

Abstract

Biomarker is a characteristic objectively measured and an indicator of biological process. This term indicates not only biological substance, for example protein, ribonucleic acid but also imaging assays. Disease biomarkers have been applied to a wide variety of clinical areas, including oncology, metabolic disorders, neurological disease and immune dysregulation. In recent years because of the progress of analysis technology, new biomarkers continue to be devised and used as diagnostic, predictive, prognostic, and toxic marker. In drug development area, biomarkers are used as surrogate endpoint to substitute for a clinical endpoint and needed for rational drug development. Here, we summarize the concept and history of biomarker.

Original languageEnglish
Pages (from-to)737-742
Number of pages6
JournalNihon rinsho. Japanese journal of clinical medicine
Volume70
Issue number5
Publication statusPublished - Jan 1 2012
Externally publishedYes

Fingerprint

Biomarkers
Immune System Diseases
Biological Phenomena
Poisons
Nervous System Diseases
Pharmaceutical Preparations
RNA
Technology
Proteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

[The concept and history of biomarker]. / Nonaka, Ryoji; Nishimura, Junichi; Mori, Masaki.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 70, No. 5, 01.01.2012, p. 737-742.

Research output: Contribution to journalReview article

Nonaka, Ryoji ; Nishimura, Junichi ; Mori, Masaki. / [The concept and history of biomarker]. In: Nihon rinsho. Japanese journal of clinical medicine. 2012 ; Vol. 70, No. 5. pp. 737-742.
@article{97d10647d4da4356b76e0cabe4f42dcb,
title = "[The concept and history of biomarker].",
abstract = "Biomarker is a characteristic objectively measured and an indicator of biological process. This term indicates not only biological substance, for example protein, ribonucleic acid but also imaging assays. Disease biomarkers have been applied to a wide variety of clinical areas, including oncology, metabolic disorders, neurological disease and immune dysregulation. In recent years because of the progress of analysis technology, new biomarkers continue to be devised and used as diagnostic, predictive, prognostic, and toxic marker. In drug development area, biomarkers are used as surrogate endpoint to substitute for a clinical endpoint and needed for rational drug development. Here, we summarize the concept and history of biomarker.",
author = "Ryoji Nonaka and Junichi Nishimura and Masaki Mori",
year = "2012",
month = "1",
day = "1",
language = "English",
volume = "70",
pages = "737--742",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "5",

}

TY - JOUR

T1 - [The concept and history of biomarker].

AU - Nonaka, Ryoji

AU - Nishimura, Junichi

AU - Mori, Masaki

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Biomarker is a characteristic objectively measured and an indicator of biological process. This term indicates not only biological substance, for example protein, ribonucleic acid but also imaging assays. Disease biomarkers have been applied to a wide variety of clinical areas, including oncology, metabolic disorders, neurological disease and immune dysregulation. In recent years because of the progress of analysis technology, new biomarkers continue to be devised and used as diagnostic, predictive, prognostic, and toxic marker. In drug development area, biomarkers are used as surrogate endpoint to substitute for a clinical endpoint and needed for rational drug development. Here, we summarize the concept and history of biomarker.

AB - Biomarker is a characteristic objectively measured and an indicator of biological process. This term indicates not only biological substance, for example protein, ribonucleic acid but also imaging assays. Disease biomarkers have been applied to a wide variety of clinical areas, including oncology, metabolic disorders, neurological disease and immune dysregulation. In recent years because of the progress of analysis technology, new biomarkers continue to be devised and used as diagnostic, predictive, prognostic, and toxic marker. In drug development area, biomarkers are used as surrogate endpoint to substitute for a clinical endpoint and needed for rational drug development. Here, we summarize the concept and history of biomarker.

UR - http://www.scopus.com/inward/record.url?scp=84864505238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864505238&partnerID=8YFLogxK

M3 - Review article

C2 - 22619994

AN - SCOPUS:84864505238

VL - 70

SP - 737

EP - 742

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 5

ER -